Recital 8, Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006…

In forcesince 17 May 2006

It is imperative that products manufactured pursuant to this Regulation reach only those who need them and are not diverted from those for whom they were intended. The issuing of compulsory licences under this Regulation must therefore impose clear conditions upon the licensee as regards the acts covered by the licence, the identification of the pharmaceutical products manufactured under the licence and the countries to which the products will be exported.